header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The Bd37 is an erythrocyte binding protein anchored at the surface of the parasite Babesia divergens. B. divergens is an Apicomplexa parasite, mostly […]
Here, we describe a simple, behaviour-based approach to identify in vivo novel psycho-active molecules in zebrafish embryos. Using an automated […]
We can offer and produce selective AEBS lignads for research purpose only.These compounds are potent inducers of breast cancer cell differentiation […]
Expression vectors encoding human cellular fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) ; […]
Comprehensive inventory of 5,000 rare diseases, indexed with ICD10, OMIM, genes (HGNC nomenclature), swissprot, genatlas, class of prevalence, class […]
Directory of 5,000 ongoing academic research projects funded at national or European level in 36 countries, classified by disease and health product […]
We isolate renal proximal tubular cells using the proximal tubular marker Prominin-1.We use a […]
Proximal tubular cells are isolated by magnetic sorting coupled with microbeads-conjugated […]
HG5LN were generated by transfection of cervical cancer HeLa cells with the […]
Overexpression and activation of TMP3-ALK tyrosine kinase fusion protein is a causal oncogenic event […]
Saccharomyces cerevisiae expressing under the GAL promoter either the wild-type rat liver CPT1, […]
HAHLH were generated by transfection of cervical cancer HeLa cells with the […]
HRLN were generated by transfection of cervical cancer HeLa cells with the […]
UG5LN were generated by transfection of osteocarcinoma cancer U2OS cells with the […]
UALH were generated by transfection of osteocarcinoma cancer U2OS cells with the […]
HELN were generated by transfection of cervical cancer HeLa cells with the […]